- Home
- MFH vs TKNO Comparison
MFH vs TKNO Comparison
Compare MFH & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFH
- TKNO
- Stock Information
- Founded
- MFH 2011
- TKNO 1996
- Country
- MFH United States
- TKNO United States
- Employees
- MFH N/A
- TKNO N/A
- Industry
- MFH Finance: Consumer Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- MFH Finance
- TKNO Health Care
- Exchange
- MFH Nasdaq
- TKNO Nasdaq
- Market Cap
- MFH 372.5M
- TKNO 356.4M
- IPO Year
- MFH N/A
- TKNO 2021
- Fundamental
- Price
- MFH $6.08
- TKNO $6.96
- Analyst Decision
- MFH
- TKNO Buy
- Analyst Count
- MFH 0
- TKNO 1
- Target Price
- MFH N/A
- TKNO $5.00
- AVG Volume (30 Days)
- MFH 92.0K
- TKNO 421.5K
- Earning Date
- MFH 05-16-2025
- TKNO 05-08-2025
- Dividend Yield
- MFH N/A
- TKNO N/A
- EPS Growth
- MFH N/A
- TKNO N/A
- EPS
- MFH N/A
- TKNO N/A
- Revenue
- MFH $1,007,430.00
- TKNO $38,250,000.00
- Revenue This Year
- MFH N/A
- TKNO $9.58
- Revenue Next Year
- MFH N/A
- TKNO $15.97
- P/E Ratio
- MFH N/A
- TKNO N/A
- Revenue Growth
- MFH 125.92
- TKNO 3.79
- 52 Week Low
- MFH $1.03
- TKNO $1.16
- 52 Week High
- MFH $8.86
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- MFH 47.24
- TKNO 63.43
- Support Level
- MFH $5.30
- TKNO $5.70
- Resistance Level
- MFH $7.90
- TKNO $6.85
- Average True Range (ATR)
- MFH 0.81
- TKNO 0.50
- MACD
- MFH -0.08
- TKNO 0.03
- Stochastic Oscillator
- MFH 30.00
- TKNO 70.79
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.